Anti-NMDAR Encephalitis: Clinical Trials

3 trials for Anti-NMDAR Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Anti-NMDAR Encephalitis: new trials by email Literature Review of Anti-NMDAR Encephalitis trials Research Report on Anti-NMDAR Encephalitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of a Novel DAB Chromogenic Tissue-Based Assay for Detecting Anti-GABABR Antibodies
Autoimmune Encephalitis, Anti-NMDAR Encephalitis
Not yet recruitingThird Affiliated Hospital, Sun Yat-Sen University3002026-10-012026-10-05
Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
IA session, Rituximab - Anti-NMDAR Encephalitis
Phase 2CompletedAssistance Publique - Hôpitaux de Paris202021-06-232026-08-10
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Optic Neuritis, Transverse Myelitis
RecruitingUniversity of Bern5002020-04-142024-12-16

Narrower conditions

Anti-N-Methyl-D-Aspartate Receptor Encephalitis (3)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Encephalitis (1)  ·  Encephalomyelitis, Acute Disseminated (1)  ·  Lupus Vasculitis, Central Nervous System (1)  ·  Multiple Sclerosis (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Myelitis, Transverse (1)  ·  Neuromyelitis Optica (1)  ·  Optic Neuritis (1)  ·  Vasculitis, Central Nervous System (1)

Broader conditions

Autoimmune Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Immune System Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Neurodegenerative Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  Paraneoplastic Syndromes (3)  ·  Paraneoplastic Syndromes, Nervous System (3)  ·  Encephalitis (2)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cardiovascular Diseases (1)

Interventions

Rituximab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Third Affiliated Hospital, Sun Yat-Sen University (1)  ·  University of Bern (1)

Countries

China (1)  ·  France (1)  ·  Switzerland (1)

Top investigators

Sandra Bigi, PD MD (1)  ·  Wei Qiu, MD (1)

NIH funding

2019 (1)